Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Medium Chain Triglyceride INTervention for Alzheimer Disease (A MINT for AD)

NCT02912936 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT02912936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02912936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Medium Chain Triglyceride INTervention for Alzheimer Disease (A MINT for AD)
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2016
Completion date
March 1, 2020
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, frontotemporal dementia (ftd), primary progressive non-fluent aphasia